The low-valent cobalt complex Co(PMe3)4 was previously reported to catalyze the hydrophosphination of phenylacetylene with HPPh2 to yield (E)-PhCH═CH(PPh2) exclusively. This work provides a more in-depth analysis of the catalytic system showing that Co(PMe3)4 is contaminated with HCo(PMe3)4. The impurity undergoes a reversible ligand exchange reaction with HPPh2 to form a series of new cobalt hydrides with the formula HCo(PMe3)4–x(HPPh2)x (x = 1–4). One of these hydride complexes, namely, HCo(PMe3)3(HPPh2), features a doublet of quartets for the hydride resonance, which was previously misassigned to the paramagnetic Co(II) complex, HCo(PMe3)3(PPh2). The contaminated Co(PMe3)4 reacts with HPPh2, under heating, to generate a dinuclear cobalt complex, (Me3P)2Co(μ-PPh2)2Co(PMe3)2. In addition to “Co(PMe3)4”, the independently synthesized HCo(PMe3)4, HCo(HPPh2)4, and (Me3P)2Co(μ-PPh2)2Co(PMe3)2 all prove to be catalytically competent. Regardless of the cobalt catalysts examined herein, both (Ph2P)CPh═CH2 and (Z)-PhCH═CH(PPh2) are present as minor hydrophosphination products.
Building similarity graph...
Analyzing shared references across papers
Jayawardhena et al. (Mon,) studied this question.
Loading...
Organometallics
University of Cincinnati
Add This Paper to Your Research Feed
Any time a new paper drops it will be there.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: